Ajooni Biotech Ratios

Ajooni Biotech Ltd Ratios

The Ajooni Biotech Ltd Ratios page provides a complete fundamental analysis of Ajooni Biotech Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Ajooni Biotech Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Ajooni Biotech Ltd (NSE: AJOONI, BSE: 535040) is currently trading at ₹4.05, with a market capitalization of ₹664.86M. As a major player in the Miscellaneous sector and Miscellaneous industry, Ajooni Biotech Ltd remains a key stock for fundamental analysis using Ajooni Biotech Ltd Ratios.

Ajooni Biotech Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Ajooni Biotech Ltd P/E ratio currently stands at 28.60, making it one of the most tracked metrics in Ajooni Biotech Ltd Ratios.

Historically, the Ajooni Biotech Ltd P/E ratio has shown strong fluctuations:

• 2024: 28.60
• 2023: 23.92
• 2022: 2.04
• 2021: 64.20
• 2020: 81.50

The rising Ajooni Biotech Ltd P/E ratio indicates increasing investor confidence and premium valuation.

Price to Book Ratio (P/B)

The Ajooni Biotech Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 1.10.

Historical P/B trend:

• 2024: 1.10
• 2023: 1.21
• 2022: 0.83
• 2021: 4.11

Ajooni Biotech Ltd shows reasonable valuation compared to its asset base.

Price to Sales Ratio (P/S)

The Ajooni Biotech Ltd P/S ratio currently stands at 0.84, an important part of Ajooni Biotech Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 0.84
• 2023: 0.65
• 2022: 0.03
• 2021: 0.91

The rising Ajooni Biotech Ltd P/S ratio indicates improved revenue valuation by investors.

Ajooni Biotech Ltd Price to Cash Flow Ratio (P/CF)

The Ajooni Biotech Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 0.

Historical Ajooni Biotech Ltd Price to Cash Flow Ratio:

• 2024: 0
• 2023: 2.26
• 2022: 0
• 2021: 21.42
• 2020: 53.19

The declining Ajooni Biotech Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

Ajooni Biotech Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Ajooni Biotech Ltd EV currently stands at ₹915.66M, representing the total company valuation including debt.

Historical EV trend:

• 2024: 915.66M
• 2023: 534.32M
• 2022: 71.59M
• 2021: 726.31M

Ajooni Biotech Ltd enterprise value shows long-term growth, reflecting expansion and market confidence.

EV/EBITDA Ratio

The Ajooni Biotech Ltd EV/EBITDA ratio is currently 24.54, a key metric in Ajooni Biotech Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 24.54
• 2023: 23.73
• 2022: 2.58
• 2021: 23.54

Higher Ajooni Biotech Ltd EV/EBITDA suggests premium valuation.

Ajooni Biotech Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Ajooni Biotech Ltd D/E ratio is currently 0.02, reflecting leverage and financial stability.

Historical D/E:

• 2024: 0.02
• 2023: 0.05
• 2022: 0.12
• 2021: 0.33

Ajooni Biotech Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The Ajooni Biotech Ltd ROE currently stands at 5.16%, showing profitability and capital efficiency.

Historical ROE:

• 2024: 5.16
• 2023: 5.12
• 2022: 3.87
• 2021: 6.55

Declining ROE indicates pressure on profitability.

Ajooni Biotech Ltd Ratios Analysis Summary

The Ajooni Biotech Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Ajooni Biotech Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Ajooni Biotech Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.